Pre-implantation Genetic Disorder/PGD HLA Typing Single Embryo Test
Test Name: Pre-implantation Genetic Disorder/PGD HLA Typing Single Embryo Test
Components: Please request collection material
Price: 4400.0 AED
Sample Condition: Trophectoderm
Report Delivery: 3 weeks
Method: Sanger Sequencing
Test Type: Genetics
Doctor: Gynecologist
Test Department: Pre Test Information
Pre Test Information
Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details
Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) is a type of genetic testing that is performed during the in vitro fertilization (IVF) process. This test is used to determine if a single embryo is a match for a sibling who requires a bone marrow transplant.
The test involves removing one or two cells from the embryo and analyzing them to determine the human leukocyte antigen (HLA) type. HLA is a group of proteins found on the surface of cells that play a critical role in the immune system’s ability to recognize and respond to foreign substances.
If the embryo is a match for the sibling in need of a bone marrow transplant, it can be implanted into the mother’s uterus, and the baby can be born and used as a donor for the sibling.
This type of testing is typically recommended for families who have a child with a life-threatening genetic disorder that can be treated with a bone marrow transplant.
PGD HLA Typing is a controversial topic as it involves selecting embryos based on their genetic makeup. Critics argue that it raises ethical concerns and could lead to the creation of “designer babies.” However, proponents argue that it provides a life-saving option for families in need and can prevent the birth of a child with a genetic disorder.
Test Name | Pre-implantation Genetic DisorderPGD HLA Typing Single Embryo Test |
---|---|
Components | Please request collection material |
Price | 4400.0 AED |
Sample Condition | Trophectoderm |
Report Delivery | 3 weeks |
Method | Sanger Sequencing |
Test type | Genetics |
Doctor | Gynecologist |
Test Department: | |
Pre Test Information | Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) is a type of genetic testing that is performed during the in vitro fertilization (IVF) process. This test is used to determine if a single embryo is a match for a sibling who requires a bone marrow transplant. The test involves removing one or two cells from the embryo and analyzing them to determine the human leukocyte antigen (HLA) type. HLA is a group of proteins found on the surface of cells that play a critical role in the immune system’s ability to recognize and respond to foreign substances. If the embryo is a match for the sibling in need of a bone marrow transplant, it can be implanted into the mother’s uterus, and the baby can be born and used as a donor for the sibling. This type of testing is typically recommended for families who have a child with a life-threatening genetic disorder that can be treated with a bone marrow transplant. PGD HLA Typing is a controversial topic as it involves selecting embryos based on their genetic makeup. Critics argue that it raises ethical concerns and could lead to the creation of “designer babies.” However, proponents argue that it provides a life-saving option for families in need and can prevent the birth of a child with a genetic disorder. |